700 Pennsylvania Drive
Exton, PA 19341
United States
610-232-0100
https://www.frontagelab.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 1,759
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. Song Li Ph.D. | Founder & Chairman | 772k | N/D | 1957 |
Dr. Abdul Ezaz Mutlib Ph.D. | Chief Executive Officer | 830k | N/D | 1961 |
Mr. Jun Gao | CFO & President of Asia Pacific | 9k | N/D | 1976 |
Mr. Richard Fischetti J.D. | VP & General Counsel of Frontage Labs | N/D | N/D | 1983 |
Dr. Zhongping Lin Ph.D. | President of Frontage Labs | N/D | N/D | 1964 |
Dr. Dongmei Wang Ph.D. | Executive Vice President for Global Project Management | N/D | N/D | 1965 |
Dr. Tianyi Zhang | Senior VP of the Group & GM of Frontage Shanghai | N/D | N/D | 1969 |
Mr. Sudendra Rao Ph.D. | Senior Vice President of Human Resources - North America | N/D | N/D | N/D |
Dr. Wentao Zhang Ph.D. | Executive Vice President of Global Drug Discovery Services | N/D | N/D | N/D |
Dr. John Kapeghian Ph.D. | Executive Vice President of Global Safety & Toxicology | N/D | N/D | N/D |
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services. The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited.
La calificación ISS Governance QuickScore de Frontage Holdings Corporation a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.